ArticleFrontiers in oncology2023

Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage

Jonathan W Goldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.